Antiproliferative and apoptosis induction of cucurbitacin-type triterpenes from Ibervillea sonorae

Industrial Crops and Products

Volumn 77, Issue , 2015, Pages 895-900

  Torres Moreno, H ^a   Velazquez C A ^a   Garibay Escobar, A ^a   Curini, Massimo ^b   Marcotullio, M C ^b   Robles Zepeda, R E ^a  

^a UNIVERSIDAD DE SONORA   (Mexico)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Antiproliferative activity; Apoptosis; Ibervillea sonorae; IC50

Indexed keywords

CELL CULTURE; CYTOLOGY;

ANTI-PROLIFERATIVE; ANTI-PROLIFERATIVE ACTIVITIES; APOPTOSIS INDUCTION; CANCER CELL LINES; CELL LINES; IBERVILLEA SONORAE; SPECTROSCOPIC TECHNIQUE; TRITERPENES;

CELL DEATH;

APOPTOSIS; BIOCHEMICAL COMPOSITION; CELLS AND CELL COMPONENTS; CHROMATOGRAPHY; FLOW CYTOMETRY; TERPENE; TOXICITY TEST;

IBERVILLEA;

EID: 84944184721     PISSN: 09266690     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.indcrop.2015.09.055     Document Type: Article

References (50)

1. Achenbach H., Horn K., Domínguez X., Rombold C., Gómez E. Cucurbitanes and cucurbitane-type glycosides from Ibervillea sonorae. Phytochemistry 1993, 33(2):437-445.
2. Alarcon-Aguilar F.J., Calzada-Bermejo R., Hernandez-Galicia E., Ruiz-Angeles C., Roman-Ramos R. Acute and chronic hypoglycemic effect of Ibervillea sonorae root extracts-II. J. Ethnopharmacol. 2005, 97(3):447-452.
3. Alonso-Castro A.J., Villarreal M.L., Salazar-Olivo L.A., Gomez-Sanchez M., Dominguez F., Garcia-Carranca A. Mexican medicinal plants used for cancer treatment: pharmacological, phytochemical and ethnobotanical studies. J. Ethnopharmacol. 2011, 133:945-972.
4. Andrade-Cetto A., Heinrich M. Mexican plants with hypoglycaemic effect used in the treatment of diabetes. J. Ethnopharmacol. 2005, 99(3):325-348.
5. Bartalis J., Halaweish F.T. In vitro and QSAR studies of cucurbitacins on HepG2 and HSC-T6 liver cell lines. Bioorg. Med. Chem. 2011, 19:2757-2766.
6. Bouchier L., Muñoz C., Connell S., Green D.R. Measuring apoptosis at the single cell level. Methods 2008, 44(3):222-228.
7. Bromberg J.F., Wrzeszczynska M.H., Devgan G., Zhao Y., Pestell R.G., Albanese C., Darnell J.E. Stat3 as an oncogenes. Cell 1999, 98:295-303.
8. Cella D., Fallowfield L.J. Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy. Breast Cancer Res. Treat. 2008, 107(2):167-180.
9. Choudhary K., Singh M., Pillai U. Ethnobotanical survey of Rajasthan-an update. Am. Eurasian J. Bot. 2008, 1(2):38-45.
10. Chung S.O., Kim Y.J., Park S.U. An updated review of cucurbitacins and their biological and pharmacological activities. Excli J. 2015, 14:562-566.
11. Cragg G.M., Newman D.J. Plants as a source of anti-cancer agents. J. Ethnopharmacol. 2005, 100(1-2):72-79.
12. Duangmano S., Sae-lim P., Suksamrarn A., Domann F.E., Patmasiriwat P. Cucurbitacin B inhibits human breast cancer cell proliferation through disruption of microtubule polymerization and nucleophosmin/B23 translocation. BMC Complement. Altern. Med. 2012, 12:185.
13. Eschenhagen T., Force T., Ewer M.S., Keulenaer G.W., Suter T.M., Anker S.D., Avkiran M., Azambuja E., Balligand J.C., Brutsaert D.L., Condorelli G., Hansen A., Heymans S., Hill J.A., Hrisch E., Hilfiker-Kleiner D., Janssen S., Jong S., Neubauer G., PIeske B., Ponikowski P., Pirmohamed M., Rauchhaus M., Sawyer D., Sudgen P.H., Wojta J., Zannad F., Shah A.M. Cardiovascular side effects of cancer therapies: a position statement from the heart failure association of the European society of cardiology. Eur. J. Heart Fail. 2011, 13(1):1-10.
14. Fischer U., Schulze-Osthoff K. Apoptosis-based therapies and drug targets. Cell Death Dis. 2005, 12:942-961.
15. Fuchs Y., Steller H. Live to die another way: modes of programmed cell death and the signals emanating from dying cells. Nat. Rev. Mol. Cell Biol. 2015, 16:329-344.
16. Fulda S. Modulation of apoptosis by natural products for cancer therapy. Planta Med. 2010, 76(11):1075-1079.
17. Haritunians T., Gueller S., Zhang L., Badr R., Yin D., Xing H., Fung M.C., Koeffler H.P. Cucurbitacin B induces differentiation, cell cycle arrest, and actin cytoskeletal alterations in myeloid leukemia cells. Leukemia Res. 2008, 32:1366-1373.
18. Hassan M., Watari H., AbuAlmaaty A., Ohba Y., Sakuragi N. Apoptosis and molecular targeting therapy in cancer. Biomed. Res. Int. 2014, 2014. 23 pages.
19. Heinrich M., Ankli A., Frei B., Weimann C., Sticher O. Medicinal plants in Mexico: healers' consensus and cultural importance. Soc. Sci. Med. 1998, 47(11):1859-1871.
20. Henry C.M., Hollville E., Martin S.J. Measuring apoptosis by microscopy and flow cytometry. Methods 2013, 61(2):90-97.
21. Hernández-Galicia E., Calzada F., Roman-Ramos R., Alarcón-Aguilar F. Monoglycerides and fatty acids from Ibervillea sonorae root: isolation and hypoglycemic activity. Planta Med. 2007, 73(3):236-240.
22. Ibrahim B., Sowemimo A., Spies L., Koekomoer T., van de Venter M., Odukoya O.A. Antiproliferative and apoptosis inducing activity of Markhamia tomentosa leaf extract on HeLa cells. J. Ethnopharmacol. 2013, 149(3):745-749.
23. Igney F.H., Krammer P.H. Immune escape of tumors: apoptosis resistance and tumor counterattack. J. Leukoc. Biol. 2002, 71(6):907-920.
24. Indran I.R., Tufo G., Pervaiz S., Brenner C. Recent advances in apoptosis: mitochondria and drug resistance in cancer cells. Biochim. Biophys. 2011, 1807:735-745.
25. Jardón-Delgado A., Magos-Guerrero G.A., Martínez-Vázquez M. Isolation of a new anti-inflammatory 20,21,22,23,24,25,26,27-octanorcucurbitacin-type triterpene from Ibervillea sonorae. Nat. Prod. Commun. 2014, 9(1):15-16.
26. Jayaprakasam B., Seeram N.P., Nair M.G. Anticancer and antiinflammatory activities of cucurbitacins from Cucurbita andreana. Cancer Lett. 2003, 189(1):11-16.
27. Jimenez-Estrada M., Velázquez-Contreras C., Garibay-Escobar A., Sierras-Canchola D., Lapizco-Velázquez R., Ortiz-Sandoval C., Burgos-Hernández A., Robles-Zepeda R.E. In vitro antioxidant and antiproliferative activities of plants of the ethnopharmacopeia from northwest of Mexico. BMC Complement. Altern. Med. 2013, 13:12.
28. Kasibhatla S., Tseng B. Why target apoptosis in cancer treatment?. Mol. Cancer Ther. 2003, 2(6):573-580.
29. Kaushik U., Aeri V., Mir S.R. Cucurbitacins-an insight into medicinal leads from nature. Pharmacogn. Rev. 2015, 9(17):12-18.
30. Lee S.H., Lee J.Y., Jung C.L., Bae I.H., Suh K.H., Ahn Y.G., Jin D.H., Kim T.W., Suh Y., Jang S.J. A novel antagonist to the inhibitors of apoptosis (IAPs) potentiates cell death in EGFR-overexpressing non-small-cell lung cancer cells. Cell Death Dis. 2014, 5.
31. Mans D.R., da Rocha A.B., Schwartsmann G. Anti-cancer drug discovery and development in Brazil: targeted plant collection as a rational strategy to acquire candidate anti-cancer compounds. Oncologist 2000, 5(3):185-198.
32. McClatchey W.C., Mahady G.B., Bennett B.C., Shiels L., Savo V. Ethnobotany as a pharmacological research tool and recent developments in CNS-active natural products from ethnobotanical sources. Pharmacol. Ther. 2009, 123(2):239-254.
33. Poon I.K.H., Lucas C.D., Rossi A.G., Ravichandran K.S. Apoptotic cell clearance: basic biology and therapeutic potential. Nat. Rev. Immunol. 2014, 14:166-180.
34. Rascón-Valenzuela L., Jiménez-Estrada M., Velázquez-Contreras C., Garibay-Escobar A., Vilegas W., Campaner L., Coqueiroc A., Robles-Zepeda R.E. Chemical composition and antiproliferative activity of Acalypha califórnica. Ind. Crops Prod. 2015, 69:48-54.
35. Rieger A.J., Nelson K.L., Konowalchuk J.D., Barreda D.R. Modified annexin V/propidium iodide apoptosis assay for accurate assessment of cell death. J. Vis. Exp. 2011, 50:2597.
36. Rivera-Ramirez F., Escalona-Cardoso G.N., Garduno-Siciliano L., Galaviz-Hernandez C., Paniagua-Castro N. Antiobesity and hypoglycaemic effects of aqueous extract of Ibervillea sonorae in mice fed a high-fat diet with fructose. J. Biomed. Biotechnol. 2011, 2011:6.
37. Ruiz-Bustos E., Velazquez C., Garibay-Escobar A., García M., Plascencia-Jatomea M., Cortez-Rocha M.O., Hernandez-Martínez J., Robles-Zepeda R.E. Antibacterial and antifungal activities of some Mexican medicinal plants. J. Med. Food 2009, 12(6):1398-1402.
38. Saraste A., Pulkki K. Morphologic and biochemical hallmarks of apoptosis. Cardiovasc. Res. 2000, 45(3):528-537.
39. Siegel R., Ma J., Zhaohui Z., Jemal A. Cancer statistics. CA Cancer J. Clin. 2014, 64:9-29.
40. Silva I.T., Carvalho A., Lang K.L., Dudek S.E., Masemann D., Durán F.J., Caro M.S.B., Rapp U.R., Wixler V., Schenkel E.P., Simões C.M.O., Ludwig S. In vitro and in vivo antitumor activity of a novel semisynthetic derivative of cucurbitacin B. PLoS One 2015, 10.1371/journal.pone.0117794.
41. Smolewski P., Robak T. Inhibitors of apoptosis proteins (IAPs) as potential molecular targets for therapy of hematological malignancies. Curr. Mol. Med. 2011, 11(8):633-649.
42. Tannin-Spitz T., Grossman S., Dovrat S., Gottlieb H.E., Bergman M. Growth inhibitory activity of cucurbitacin glucosides isolated from Citrullus colocynthis on human breast cancer cells. Biochem. Pharmacol. 2007, 73(1):56-67.
43. Taatjes D.J., Sobel B.E., Budd R.C. Morphological and cytochemical determination of cell death by apoptosis. Histochem. Cell Biol. 2008, 129(1):33-43.
44. Tait S.W.G., Ichim G., Green D.R. Die another way-non-apoptotic mechanisms of cell death. J. Cell Sci. 2014, 127:2135-2144.
45. AK.C3F6. Licenciatura 2011, Universidad de Sonora.
46. Valerio L.G., Gonzales G.F. Toxicological aspects of the South American herbs cat's claw (Uncaria tomentosa) and Maca (Lepidium meyenii): a critical synopsis. Toxicol. Rev. 2005, 24(1):11-35.
47. Van den Eijnde S.M., Boshart L., Baehrecke E.H., de Zeeuw C.I., Reutelingsperger C.P., Vermeij-Keers C. Cell surface exposure of phosphatidylserine during apoptosis is phylogenetically conserved. Apoptosis 1998, 3:9-16.
48. Vermes I., Haanen C., Steffens-Nakken H., Reutelingsperger C. A novel assay for apoptosis flow cytometric detection of phosphatidylserine early apoptotic cells using fluorescein labeled expression on annexin V. J. Immunol. Methods 1995, 184:39-51.
49. Wong R.S.Y. Apoptosis in cancer: from pathogenesis to treatment. J. Exp. Clin. Can. Res. 2011, 30:87.
50. Ziegler U., Groscurth P. Morphological features of cell death. News Physiol. Sci. 2004, 19:124-128.